Lexicon Pharmaceuticals, Inc. (LXRX)

Lexicon Pharmaceuticals Statistics

Total Valuation

LXRX has a market cap or net worth of $988.13 million. The enterprise value is $860.49 million.

Market Cap	988.13M
Enterprise Value	860.49M

Important Dates

The last earnings date was Thursday, May 7, 2026, before market open.

Earnings Date	May 7, 2026
Ex-Dividend Date	n/a

Share Statistics

LXRX has 444.10 million shares outstanding. The number of shares has increased by 6.70% in one year.

Current Share Class	444.10M
Shares Outstanding	444.10M
Shares Change (YoY)	+6.70%
Shares Change (QoQ)	+10.13%
Owned by Insiders (%)	1.32%
Owned by Institutions (%)	29.23%
Float	218.76M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	14.09
Forward PS	45.88
PB Ratio	4.36
P/TBV Ratio	6.20
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	12.36
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.24
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2.99

Financial Efficiency

Return on equity (ROE) is -16.01% and return on invested capital (ROIC) is -6.29%.

Return on Equity (ROE)	-16.01%
Return on Assets (ROA)	-5.35%
Return on Invested Capital (ROIC)	-6.29%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	9.76%
Revenue Per Employee	$859,790
Profits Per Employee	-$322,086
Employee Count	81
Asset Turnover	0.25
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +291.23% in the last 52 weeks. The beta is 0.97, so LXRX's price volatility has been similar to the market average.

Beta (5Y)	0.97
52-Week Price Change	+291.23%
50-Day Moving Average	1.79
200-Day Moving Average	1.44
Relative Strength Index (RSI)	63.39
Average Volume (20 Days)	3,011,956

Short Selling Information

The latest short interest is 23.86 million, so 5.37% of the outstanding shares have been sold short.

Short Interest	23.86M
Short Previous Month	23.67M
Short % of Shares Out	5.37%
Short % of Float	10.91%
Short Ratio (days to cover)	12.18

Income Statement

In the last 12 months, LXRX had revenue of $69.64 million and -$26.09 million in losses. Loss per share was -$0.07.

Revenue	69.64M
Gross Profit	63.00M
Operating Income	-24.23M
Pretax Income	-26.09M
Net Income	-26.09M
EBITDA	-23.63M
EBIT	-24.23M
Loss Per Share	-$0.07

Balance Sheet

The company has $170.66 million in cash and $49.68 million in debt, with a net cash position of $120.97 million or $0.27 per share.

Cash & Cash Equivalents	170.66M
Total Debt	49.68M
Net Cash	120.97M
Net Cash Per Share	$0.27
Equity (Book Value)	202.86M
Book Value Per Share	0.51
Working Capital	199.66M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	600,250
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 90.46%, with operating and profit margins of -34.79% and -37.46%.

Gross Margin	90.46%
Operating Margin	-34.79%
Pretax Margin	-37.46%
Profit Margin	-37.46%
EBITDA Margin	-33.93%
EBIT Margin	-34.79%
FCF Margin	n/a

Dividends & Yields

LXRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.70%
Shareholder Yield	-6.70%
Earnings Yield	-2.66%
FCF Yield	n/a

Analyst Forecast

The average price target for LXRX is $3.72, which is 67.19% higher than the current price. The consensus rating is "Buy".

Price Target	$3.72
Price Target Difference	67.19%
Analyst Consensus	Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	40.95%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 21, 2015. It was a reverse split with a ratio of 1:7.

Last Split Date	May 21, 2015
Split Type	Reverse
Split Ratio	1:7

Scores

Altman Z-Score	n/a
Piotroski F-Score	3